An open label, randomized clinical trial to compare the tolerability and efficacy of ivermectin plus diethylcarbamazine and albendazole vs. diethylcarbamazine plus albendazole for treatment of brugian filariasis in Indonesia by Supali, Taniawati et al.
Washington University School of Medicine 
Digital Commons@Becker 
Open Access Publications 
2021 
An open label, randomized clinical trial to compare the tolerability 
and efficacy of ivermectin plus diethylcarbamazine and 
albendazole vs. diethylcarbamazine plus albendazole for 











See next page for additional authors 
Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs 
Recommended Citation 
Supali, Taniawati; Djuardi, Yenny; Christian, Michael; Iskandar, Elisa; Alfian, Rahmat; Maylasari, Roospita; 
Destani, Yossi; Lomiga, Adriani; Minggu, Dominikus; Lew, Daphne; Bogus, Joshua; Weil, Gary J; and 
Fischer, Peter U., ,"An open label, randomized clinical trial to compare the tolerability and efficacy of 
ivermectin plus diethylcarbamazine and albendazole vs. diethylcarbamazine plus albendazole for 
treatment of brugian filariasis in Indonesia." PLoS Neglected Tropical Diseases.,. . (2021). 
https://digitalcommons.wustl.edu/open_access_pubs/10095 
This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been 
accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker. 
For more information, please contact engeszer@wustl.edu. 
Authors 
Taniawati Supali, Yenny Djuardi, Michael Christian, Elisa Iskandar, Rahmat Alfian, Roospita Maylasari, 
Yossi Destani, Adriani Lomiga, Dominikus Minggu, Daphne Lew, Joshua Bogus, Gary J Weil, and Peter U. 
Fischer 
This open access publication is available at Digital Commons@Becker: https://digitalcommons.wustl.edu/
open_access_pubs/10095 
This document is a placeholder for the final pdf or accepted manuscript of: 
 
An open label, randomized clinical trial to compare the tolerability and efficacy of ivermectin plus 
diethylcarbamazine and albendazole vs. diethylcarbamazine plus albendazole for treatment of brugian 
filariasis in Indonesia 
